• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 0.00% 0.6¢

INVION LIMITED

Invion Limited is an Australia-based life sciences company. The Company is engaged in the... Invion Limited is an Australia-based life sciences company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVX 07/03/24 17 4.5K
07/03/24 Last post  1MRX Comments Created with Sketch.  17  Views Created with Sketch.  4.5K 
IVX 05/03/24 0 223
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
IVX
ACHIEVING ~80% TUMOUR CONTROL IN PRECLINICAL STUDIES
05/03/24 0 168
05/03/24 Last post  cashngrab Comments Created with Sketch.  0  Views Created with Sketch.  168 
IVX 28/02/24 0 206
28/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  206 
IVX 24/02/24 2 1.0K
24/02/24 Last post  Rtj1953 Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
IVX
ASX:IVX - Latest research update on Invion from Pitt Street
24/02/24 2 961
24/02/24 Last post  Chuckm61 Comments Created with Sketch.  2  Views Created with Sketch.  961 
IVX
Invion's Chair and CEO appointed to Advisory Board of Stanford Medicine CARE
16/02/24 0 339
16/02/24 Last post  Rtj1953 Comments Created with Sketch.  0  Views Created with Sketch.  339 
IVX 31/01/24 5 1.8K
31/01/24 Last post  cashflowmonday Comments Created with Sketch.  5  Views Created with Sketch.  1.8K 

See All Discussions arrow Created with Sketch.

Timeline

Presentation at East-West Summit in Singapore
05 Mar 08:37
 
INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
04 Mar 16:06
 
Appendix 4D and Half Year Financial Report
28 Feb 09:29
 
Agreement with Dr.inB to develop Photosoft treatment for HPV
23 Feb 09:04
 
Activities Report and Appendix 4C
30 Jan 08:55
 
Change of Director's Interest Notice- Robert Merriel
19 Jan 09:22
 
View More arrow Created with Sketch.
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $38.54M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $2.19K 370K

Buyers (Bids)

No. Vol. Price($)
6 7647169 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 3269584 8
View Market Depth
Last trade - 11.31am 19/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.5¢ 205000
Last updated 11.33am 19/03/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.